Makers Laboratories Ltd

Makers Laboratories Ltd

₹ 152 2.46%
24 Apr 12:23 p.m.
About

Incorporated in 1984, Makers Laboratories
Ltd is in the business of manufacturing and marketing of pharmaceuticals

Key Points

Business Overview:[1][2][3]
The company markets 200+ generic formulations in India across major therapeutic segments like anti-malarial, antibiotics, anti-inflammatory, analgesics, and anti-diabetics, catering to dispensing doctors, nursing homes, and hospitals. It also undertakes job work for injectables (anti-malarial) for IPCA and procures products on a P2P basis from manufacturers in Himachal Pradesh and Uttarakhand's excise-free zones.

  • Market Cap 89.7 Cr.
  • Current Price 152
  • High / Low 230 / 114
  • Stock P/E 20.0
  • Book Value 98.8
  • Dividend Yield 0.00 %
  • ROCE -7.84 %
  • ROE -12.7 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company's working capital requirements have reduced from 36.4 days to 21.2 days

Cons

  • The company has delivered a poor sales growth of 0.95% over past five years.
  • Company has a low return on equity of -8.25% over last 3 years.
  • Earnings include an other income of Rs.11.0 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
13.51 9.03 9.67 11.41 10.63 10.84 11.54 14.92 11.17 11.45 12.29 11.50 9.45
12.08 10.05 11.19 12.00 12.48 11.02 13.32 15.63 12.28 11.59 12.56 11.66 10.01
Operating Profit 1.43 -1.02 -1.52 -0.59 -1.85 -0.18 -1.78 -0.71 -1.11 -0.14 -0.27 -0.16 -0.56
OPM % 10.58% -11.30% -15.72% -5.17% -17.40% -1.66% -15.42% -4.76% -9.94% -1.22% -2.20% -1.39% -5.93%
0.04 0.08 0.13 0.69 0.14 0.18 0.19 0.69 0.12 0.15 0.14 10.19 0.57
Interest 0.39 0.40 0.37 0.33 0.40 0.28 0.35 0.41 0.42 0.46 0.39 0.33 0.13
Depreciation 0.47 0.47 0.48 0.60 0.66 0.66 0.67 0.68 0.68 0.68 0.71 0.71 0.73
Profit before tax 0.61 -1.81 -2.24 -0.83 -2.77 -0.94 -2.61 -1.11 -2.09 -1.13 -1.23 8.99 -0.85
Tax % -11.48% -11.60% 1.79% -13.25% -7.58% -12.77% -5.75% -10.81% -7.18% 37.17% -1.63% 10.57% -9.41%
0.67 -1.60 -2.27 -0.71 -2.57 -0.80 -2.46 -0.99 -1.95 -1.56 -1.22 8.03 -0.77
EPS in Rs 1.14 -2.71 -3.85 -1.20 -4.36 -1.36 -4.17 -1.68 -3.30 -2.64 -2.07 13.61 -1.30
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
61.55 68.37 64.91 61.41 58.13 55.95 46.60 51.31 44.34 52.34 42.46 48.85 44.69
57.66 65.93 60.53 56.71 52.69 51.28 44.38 48.55 41.03 49.24 46.60 52.60 45.82
Operating Profit 3.89 2.44 4.38 4.70 5.44 4.67 2.22 2.76 3.31 3.10 -4.14 -3.75 -1.13
OPM % 6.32% 3.57% 6.75% 7.65% 9.36% 8.35% 4.76% 5.38% 7.47% 5.92% -9.75% -7.68% -2.53%
1.57 0.21 0.94 0.41 1.24 1.50 2.56 0.18 0.41 0.80 1.14 1.14 11.05
Interest 0.96 0.49 0.39 0.36 0.27 0.36 0.26 0.70 1.60 1.68 1.38 1.63 1.31
Depreciation 1.01 0.97 1.53 1.25 1.08 1.57 1.50 1.99 4.20 1.91 2.40 2.71 2.83
Profit before tax 3.49 1.19 3.40 3.50 5.33 4.24 3.02 0.25 -2.08 0.31 -6.78 -6.95 5.78
Tax % 30.09% 50.42% 30.88% 34.29% 30.77% 27.83% 18.87% 148.00% -22.12% 45.16% -6.05% 0.00%
2.44 0.60 2.35 2.31 3.70 3.06 2.45 -0.12 -1.62 0.17 -6.36 -6.95 4.48
EPS in Rs 4.14 1.02 3.98 3.92 6.27 5.19 4.15 -0.20 -2.75 0.29 -10.78 -11.78 7.60
Dividend Payout % 0.00% 0.00% 20.94% 21.30% 13.30% 16.08% 20.08% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -3%
5 Years: 1%
3 Years: 3%
TTM: -8%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 172%
Stock Price CAGR
10 Years: 8%
5 Years: 28%
3 Years: -5%
1 Year: 1%
Return on Equity
10 Years: 0%
5 Years: -6%
3 Years: -8%
Last Year: -13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 4.92 4.92 4.92 4.92 4.92 4.92 4.92 4.92 4.92 4.92 5.90 5.90 5.90
Reserves 17.39 17.99 19.71 21.42 29.15 31.90 36.78 39.70 44.70 45.38 52.38 45.55 52.39
4.40 2.12 0.80 0.18 1.43 1.29 6.38 13.05 15.99 19.40 11.20 15.37 3.96
12.04 15.99 13.67 13.68 14.70 15.18 11.94 16.20 13.51 15.78 15.30 19.33 13.00
Total Liabilities 38.75 41.02 39.10 40.20 50.20 53.29 60.02 73.87 79.12 85.48 84.78 86.15 75.25
12.26 11.94 11.47 10.39 17.30 16.62 18.10 32.89 30.59 29.94 40.45 39.88 31.83
CWIP 0.01 1.92 2.71 4.23 0.15 0.11 6.42 0.69 0.12 8.94 0.04 0.00 0.10
Investments 4.04 2.50 2.35 2.35 7.12 9.18 11.16 15.04 23.66 22.55 22.52 22.56 22.59
22.44 24.66 22.57 23.23 25.63 27.38 24.34 25.25 24.75 24.05 21.77 23.71 20.73
Total Assets 38.75 41.02 39.10 40.20 50.20 53.29 60.02 73.87 79.12 85.48 84.78 86.15 75.25

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1.01 1.30 1.32 3.52 5.53 0.21 5.39 4.23 0.67 6.80 -1.42 -3.06
0.81 -1.12 -1.00 -1.49 -2.96 -2.06 -8.31 -8.43 -2.65 -8.78 -3.55 -2.04
-1.85 -0.45 -0.38 -0.91 0.39 -1.09 3.92 2.91 1.37 1.77 4.94 5.12
Net Cash Flow -0.03 -0.27 -0.06 1.12 2.96 -2.95 1.00 -1.29 -0.61 -0.21 -0.04 0.02

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 58.59 66.89 66.58 85.65 75.73 73.20 39.32 53.71 59.19 37.31 64.73 49.09
Inventory Days 100.40 82.37 83.67 60.14 84.04 135.66 147.65 132.22 176.97 159.36 109.67 135.03
Days Payable 90.69 86.93 68.30 73.93 75.31 67.88 49.81 90.79 98.48 52.16 61.39 127.16
Cash Conversion Cycle 68.31 62.33 81.96 71.87 84.46 140.97 137.16 95.14 137.68 144.51 113.01 56.96
Working Capital Days 65.77 65.93 71.53 71.92 44.77 79.33 72.61 44.67 82.73 43.59 44.53 21.15
ROCE % 12.82% 7.81% 13.08% 15.63% 15.54% 13.15% 7.63% 1.80% -1.05% 3.02% -7.77% -7.84%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
61.27% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.39% 0.39%
38.72% 38.73% 38.73% 38.72% 38.73% 38.73% 38.74% 38.73% 38.74% 38.73% 38.33% 38.34%
No. of Shareholders 4,7534,8394,6214,4834,4024,2834,1794,1764,0904,0084,0314,135

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents